Stenting of coronary arteries: Has a modern Pandora's box been opened?  by Serruys, Patrick W. et al.
JKC “.a,. 17. NO. 6 ,438 
May ,wI:1118-148 
NEW TECHNOLOGY 
Stenting of Coronary Arteries: Has a Modern Pandora’s Box 
Been Opened? 
PATRICK W. SERRUYS. MD, FACC, BRADLEY H. STRAUSS, MD, 
HELEEN M. VAN BEUSEKOM, MSc and WILLEM J. VAN DER GIESSEN. MD 
RomVdom, nlr ‘Ve,hr,,onlis 
lntcrvetttianal cmdioktgy has rwently witnesfd the growth 01 
sever* tentslives to prcutattm tmnslmttin* at gioptasty, 
indiidhtg mmttsry stmthtg. Although slatting appears to he 
twhl in treating abrupt clodwe atIer canary angiqdrstj. its 
etTecdveaoss in lbnitirtg the mm$ex prwxxw rmpmsiblc for late 
restew*s is mttcb k5s certainin. Patb+d@ examinatiao of aentfd 
human qbnous bypass g&s sbmvr extensive &p&s d plate. 
kts, fibrin and kukaytes alwg tbe slent wires within the 1st week 
and f~mmti~n ol a ttmintima ol variable tbicim+~ after 3 mm&s 
witbmtt evidettce UffUreign body reactan. Tbe bmg.te~,, effects al 
The intraduction of coranary balloon mtgiaplasty by An 
dress Gruentzig (I) in 1977 provided the stimulus for rapid 
technologic growth in the field of inlervenlional cardiology. 
This development has produced several new devices de- 
signed to ablate coronary anery narrowi~gs. recanalize 
occluded vessels and prevent restenasix It is ditlicult to 
evaluate the relative merits of each intervention and to 
define their r&s in clinical cardiology. In applying this new 
technology. cardiologists have limited their cUncern to the 
technical and pmcedum’ aspects, while sometimes over- 
looking the complex biologic and physiologic mechanisms of 
athemsckmsis, and in particular of the restettosis process. 
In achieving the perceived benefit of therapeutic interven- 
tion with these devices, the vessel wall is subjected to 
thermal and mechanical insults that may have hidden long- 
term consequences. An example is the restettosis process. 
which has been iatragenically induced in tens of thousands 
of patients. 
One of these newer develapments has been the use of 
endoluminal vascular prostheses, although the original con- 
cept of iaravaacular stenting precedes the introducrion of 
cUrUnary artery interventional cardiology by many years. 
Since the original description of Dotter’s tubular coil spring 
stem (2). many variants of the original cancept have been 
introduced. including thermal shape m=cmmy alloy stems 
13-6). steel spirals (7). stainless steel mesh stews (R-11). 
slotted stainless steel tubes (12-15). zigzag stems (l6-IR), 
Uconliguration bends (19). interdiitatbtg coils (20-221, 
tantalum helical coil stems (23), knitted tatttalum wire stents 
(24.25). removable, metallic mesh stems (26) and synthetic 
polymeric mnd biodegradable stems (27). There various 
devices differ greatly in their fundamental geometry WC. 
mesh or single wire). composition (metal or plastic) and 
mechanical behavior (active or passive expansimd. Further- 
more, there are a variety of subtle di&rences that may be 
impmizmt in themselves. such as thickness of filaments, 
alloy composition. ekctmstatic behavior and biocompatible 
or therapeutic oatings. 
More than 7 years have passed since the first clinical 
repott (8) of successful curmtary stem implantations. Al- 
though the currett, world experience has now exceeded 
I.0Cn.l stent implatttations. the clinical indicatimts and appli- 
cations of this pmsthesis remain undetetmined and even 
experienced investigators are uncertain on these issues. The 
current SMUS of the coronary stem parallels that of other 
recently introduced techndogic advances, incbtdittg laser 
angioplasty and adterectomy (directional and nondirectional 
types). This raises a fundamental question: have we been 
unable to realize the full pmential of these newer devices 
because of our limited understanding of the underlying 
biologic interactions, particularly those responsible for re- 
stenosis? In this review. we address several rek~ant issues 
based on our experience in the evaluation af variour core- 
nary ants. 
,44!3 SERRUYS ET At. 
~iENTtN”“FC”R”N*RY AHlERlES 
Rationale for Stenting an Atherosclerotic 
Stenosis During or After Balloon Dilation 
Short-term consideration: abrupt elmurc. Abrupt vessel 
closure after anaioolasty occurs in 2% to I I% of procedures 
(28-31). lntimal flaps jnduccd by the arterial injury can 
disrupt Row by partially or completely occluding the lumen. 
Sluggish anterogradc Row and the exposure of media to 
procoagulant blood-borne elements arc potent thrombogenic 
stimuli that further contribute to the process. The coronary 
stat. by acting as a splint. eao physically contain the 
protruding obstructive flap and maintain Row as well as 
possibly prevent distal cmholization of macroscopic debris 
originating from the plaque or Rap (32). This scaffolding 
function appears to be a propcny common to both balloon 
and self-expanding stenting prostheses. Angiographic stud- 
ies (IO) after stcnt imolantation have shown that the self- 
expanding Wallstent has a smoothing effect that reduces 
calculated poiseuille and turbulent contributions to Row 
resistance. Several reports have documented successful 
deployment of the various types of stems in the “baiLout” 
situation when the presence of intimal dissection has led to a 
poor and even critical henwdynamic result (33.34). 
Lang-term considerations: r&en&. Restenosis remains 
the major limitation of coronary augioplastyty. Despite a lack 
of uniformity of definition, several angiographic follow-up 
studies have documented a 20% to 40% incidence in the 1st 
6 months after angioplasty (35-38). Restenosis has been 
defined angiographically as a significant deterioration in the 
luminal diameter of a lesion that had previously been sue- 
cenrfully dilated, and does not neceswily indicate a eom- 
man pathologic substrate. Diverse histologic proecsscs may 
be responsible for restenosis depending on the time interval 
since angioplasty. 
Early rc&nesis. Restcnosis has been documented in up 
to I I% of lesions as early as I to 4 days after coronary 
angioplaety (38-40). It is believed that the early eases of 
angiographic worsening arc a result of several processes, 
including elastic recoil, vasospasm or platelet-fib& thrombi. 
or combinations. This time interval is too brief for significant 
fibrointimal hyperplasia to have occurred, for several rca- 
sons. Patholoeic studies (41-431 of vessels retrieved <IO 
days after angkplasty havk not shown any significant intimal 
hype&&. Animal experiments (44.45) in carotid arteries 
of rats have demonstrated that smooth muscle cell migration 
into the intima begins only at 4 days and maximal intimal 
smooth muscle cell proliferation is not noted before 7 days 
after balloon endathelial denudation. Furthermore, cell cul- 
tures of medial smooth muscle cells (46) have shown that he 
modulation of phenotype fmm the quiescent, contractile 
state (typical of normal medial smooth musdc cells) to a 
metabolically active. synthetic state occurs only after 6 to 7 
days. Smoo:h muscle cells obtained from intimal thickenings 
phenotypically resemble these synthetic-type smooth mus- 
cle cells observed in culture and share a common cytoskel- 
cton protein profile that differs from typical medial smooth 
muscle cells (47.48). 
The stat and ctmtic remit. The significance of elastic 
recoil has been demonstrated acutely during angioplasty. In 
a study of ISI dilated scgmel.ts, the minimal luminal cross- 
sectional area before angioplasty was I.1 + 0.9 mm’ (49). 
tmmediately after the procedure the cross-sectional area of 
the dilated vessel was 2.8 r I.4 mm’. Elastic recoil, defined 
as the difference between the balloon cross-sectional area 
(5.2 t 1.6 mn?) and the vessel area after angioplasty, was 
Falculated to be 2.4 + 1.4 mm*, which is almost 50% of the 
cross-sectional area of the fully inflated balloon. In an 
angiographic study of the initial I17 stent implants, we 
demonstrated that the self-expanding Wallstent mitigates the 
effects of elastic recoil. Stenting immediately improved !he 
minimal ctvsrscetional area from 3.0 f I .2 mm’ after 
angioplasty to 5.5 + 2.7 mm’. In a subgroup of patients with 
angiography 24 hours later, the stcnt continjcd to expand 
and increased the cross-sectional area to 6.8 + 4.4 mm’ 
(Scrruys et al., unpublished observations). 
Late rcstcaesis. Two processes have been implicated in 
the development of late restenosis. In some eaw it has been 
attributcd’to the organization and fibrous conversion of 
platclctdbrin thrombi that form at the site of intimal dam- 
age. However, a more important mechanism appears to be 
marked celhdar proliferation within the vessel wall that is 
stimulated by complex interactions between platelets adher- 
ent to the damaged intima, macrophagcs, endotbelial cells 
and medial smooth muscle cells. Pathologically, late rcstcno. 
sis is characterized by an aggressive proliferation of smooth 
mw.le cells that presumably have migrated from the media 
into the intima, resulting in a variable degree of tuminal 
narrowing (43.50). lmmunopcmxidase staining of the cellu- 
lar component of this tibrointimal tissue has identified the 
characteristic ytoskcleton proteins of medial smooth row- 
cle cells-alpha actitt, desmin and vimcntit+confirming the 
origin of the cells responsible for this growth. 
What Causes Smooth Muscle Cell 
Proliferation? 
Abnormal smooth muscle cell proliferation is an intricate 
process that is only partially understood. Animal models 
have revealed that balloon denudation in arteries will stim- 
ulate a sequence of events if either of two conditions is 
oresent: I) extensive endothelial denudation. or 2) significant 
medial smooth muscle cell injury. 
The pioneering work of Rcidy et al. (44.45) showed that 
significant intimal hypctplasia occurred after balloon injury 
in rat carotid arteries that resulted in the loss of up to 25% of 
the vcsscl wall deoxyribonucleic acid (DNA). This loss 
reflects widespread medial smooth muscle cell injury, since 
endothelial cell loss alone could not aeeount for such a major 
change in DNA content. Later. more sophisticated tcch- 
niques of vessel wall injury were used (51), which localized 
damage to the endothelium, sparing the subendothelium and 
medial layers. Subsequently, intimal thickenines develooed 
only in regions of the vessels that were not re&vercd with 
endothelium after 7 days. These studies suggested that 
smooth muscle cell proliferation and migration are sepa- 
rately controlled processe% because some areas of rapid 
endotbelial regrowth contained increased numbers of medial 
smooth muscle cells without a corresponding increase in 
intimal thickness. A separate serirs bf autoradiographic 
experiments (52.53) showed that only .5G% of intimal smwth 
muscle cells are capable of proliferation. supporting this 
concept. 
Fiatektderived grnwtb factor. Several mitogens have 
bee” imtalicated in the stimulation of smooth muscle cells. 
Platelet&ived growth factor. the most intensively studied 
Cactor. is a dimer compound composed of two homologous 
polypeptide chains (A and 9) that are disulfide bonded (54). 
Although platelet-derived growth factor was originally iso- 
lated Ctvm platelets, further study has confirmed that il is 
released from several ditferent cells. including vascular 
endothelium, macrophages and even activated smwth mus- 
cle cells, p&taps explaining why smooth muscle cells co”. 
tinwe to pmliierate long aCter the initial platelet-vessel wall 
interact& (55-58). 
The binding of platelet-derived growth factor to its receo. 
tar initiates a corn&x cascade of &al transduction within 
the cytoplasm and ultimately into the nucleus of the smooth 
muscle cell, resulting in cell division and protein synthesis. 
Although these pathways have not been elucidated fully. 
important steps include the platelet-derived growth factor 
receptor-mediated phosphaylation of tyrosine kinase and 
actiwtion of phospholipase C. which subsequently gener- 
ates two imponant second messengers. diacylglyceml and 
inositol triphosphate (59.60). The platelet-derived growth 
factor receptor and bath its chains have been sequewed and 
it is now wssible to clone olatekidetived mowth factor 
with rec&thinant technology. Monocloni antibodies 
against both chains of platelet-derived growth factor and its 
receptor have also bee” produced. The gene that codes for 
the B chain mRNA of &tektderived erowth factor is c-sis. 
which is the cellular counterpart to rhe v-sis gene of the 
simian sarcoma virus. An intriguing connection between 
neoplasia and atherosclerotic lesions is the demonstration of
an active human oncogene in atherosclerotic plaques 161). 
Cultured mouse libroblast NIH 3T3 cells have been trans. 
formed with transfected DNA from these plaques ,611. 
These translomted cells have established slow-growing tu- 
mors in “nude” mice. 
Dtiw growth Csctors. Other important growth factors 
that have been related to restenosis include intedeukin-I 
(lL-1). hbroblast growth factor, colony stimulating factor, 
epidermal growth factor. insulin-like growlh factor (se 
matomedins), endothelin and semtonin. The relative influ- 
ence of the individual factors and possible interactions are 
largely unknown and indicate our limited understanding of 
the entire process. 
Fiwc 1. Scanning ekctmn micmpaph of a stead human saphe- 
mm vein typasrgmft removed 3dayr a(terim&mation. Extensive 
deposits al platekts. kukcqter and fibrin are evident on this detail 
of the stem filamentr. 
Pathology of Restenasis: After Coronsry 
Angioplasty and Coronary Stenting 
Although autopsy repo”s of late follow-up angioplasty 
cases (3 to 20 months) are limited. the general consensus is 
that the characteristic features of restenosis are smooih 
muscle cell hypaplasia and a variable a”w”t of extracello- 
lar matrix and fibrosis depending on the tit% elapsed since 
angioplasty. In addition to dam from chronic animal studies, 
stented venous bypass g&s have been retrieved from 
several patients for analysis. Although the extent of intimsl 
hyperplasia is similar aller stenting to postangioplasty exam- 
ination. several histologic features appeared to be unique to 
coronary stents. 
Pathdo8ic ud hWk@c katwes. In human saphenow 
vein bypass grafts and par&e coronsry arteries retrieved 3 
to 7 days aher stent implantation, extensive dewsits of 
platelets. fibrin and leukocytes are observed alang the stent 
wires (Fig. I). I” the pig, the stent wires become embedded 
in the vessel wall and are covered with a mointima witbht 7 
days. This neointima consists of organizing thrombus di- 
rectly adjacent to the wire and several layers of smooth 
muscle cells along the luminal surface (Fig. 2). Scanning 
electmn microscopy has confirmed complete endotheliiliza- 
lion. 
Al 4 weeh in porcine coronary arreries, few traces 
remain of the initial platelet-fibrin thrombus. which is repre- 
sented by a few erythrmytes, leukocytes and lipid-laden 
foam cells that are interspened in a disorganized lihrocel- 
lhthv layer (Fig. 3). At the luminal side two distinct layers of 
smooth muscle cells are present, one in a circularorientation 
immediately below the endathelium and a deeper layer in a 
longitudinal orientation. 
After3 months. a more extensive neointimafomx in the 
porcine coronary artery with only a small area adjacent to 
the stent wire containing leukocytes and cellular debris (the 
so-called “Bermuda triangle”) (Fig. 4). In human saphenous 
vein bypass grafts removed 3 to IO months after the slatting 
procedure, the amuunt af neointima which develops is 
comparable with the ammtnt of neointima in the porcine 
coronary artery. but the neointima in humans borders on the 
old atherosclerotic plaque (Fig. 5). At the junction between 
old plaque and recent neointima. abundant foam cells and 
extracellular lipid deposits are found within the new neoint- 
ima in addition to extensive extracellular matrix production 
(Fig. 6). 
Mechanisms. The cruts~s and possible relations between 
these early and late histologic features are unknown. Two 
factors may be important. First, the regenerated endothe- 
Gum that covers the stented segment may be dysfunctional 
and thus permit abnormal and excessive lipid inliltmtion and 
macrophage penetration across the endothelial barrier. 
Scanning electron microscopy of the endothelial lining has 
indicated an irregular. raised endothelial surface in lieu of 
the normal smooth covering (Fig. 7) although no permeahil- 
ity to Evan’s blue dye was demonstrated in stented porcine 
arteries after 3 months Wan der Giessen et al., unpublished 
observations). Second. important chemotactic substances 
may be released by the cellular debris trapped in the tissue 
adjacent to the stent wires. This area appears to persist late 
after stenting for several reasons. including continued dam- 
age from direct pressure necrosis and its deeper location in 
the vessel wall. which isolates it from laminar Row patterns 
predominating on the luminal aspect of the stat wires. 
Striking similarities exist between the biology of stented 
vessels at 3 months and chronic atherosclerotic lesions, 
namely. proliferation of smooth muscle cells, large atnount~ 
of connective tissue matrix including collagen, elastin and 
Figure 2. Light micrograph of a stented 
porcine femoral artery 7 days after implan- 
tation. The void5 (*I represent the sites of 
rhe 70 q diameter stem wires. which have 
been removed. There is a disorganized layer 
ofneointimafirllon theluminal aspectofthe 
stent wire. conlaining smooth muscle cells, 
trapped red blood cells and fibrin. Above the 
disorganized layer is an organized neoinlima 
that contains smooth mu~ele cells covered 
by endothelium. The inlwnal elastic lamina 
is interrupted at the left tarrow). A = adven- 
titia: M = media. 
proteoglycans. and lipid accumulation in the form of foam 
cells (smooth muscle cells and macmphages). and extracel- 
lular deposits. The natural history of these post-stent lesions 
has not yet been determined. 
Figure 3. Light micrograph of a porcine coronary artery 4 weeks 
after implantation. showing the remnants of the initial thrombus. 
which naw contains a few erythmcytes. leukocytes and lipid-laden 
foam cells that are interspersed in a disorganized fibrocslh4ar layer. 
At the luminal side. two distinct layers of smmth muscle cells are 
present, one in a circular orientation IC) immediately below the 
endolhelium. and the other a deepr layer in a longitudinal orienta- 
tion (Lt. 1‘1 = void reprcsentinC the site of a removed 127 pm 
diameter stem wire. 
Fbwe 4. Light micrograph of a stented porcine artery 3 months 
after implaotatiott. A more extensive neointima haa Formed. with 
cadytwosmmall areas adjacnttothe stem (ui~eeontainingleukocytcs 
and celhtl~l dcbtir &mws). (9 = void representing the site of a 
removed 70 qt diameter EM wire. 
&me 5. Light micrograph ofa humar saphenous vein bypass g&t 
temwed to months a&r ant implamatkm. A prominent neointima 
tN) has Formed andbadersan the aldalbemsclerotic pksuc IW. At 
the junction between the old plaque and the went neointima. 
abundant Foam cells are faund in the new moiaima. (‘1 = void 
representing the site OF a removed 70 lun diwter stem wire. 
Stating and Hyperplasia 
Role alrleolim io hwrnlasia. Several oossible theories 
have been advancid tolp&t the role oF&nting in limiting 
intimal hvwmlasia (32.6354). However. there is minimal 
experime&l &idence to justify this position. and available 
animal and clinical studies confirm that signilicsnt hypetpla- 
sia occurs within the stented segment. The extent and 
characteristics of this hyperplasia are illustrated by the case 
of a 61 year old man who had ~ecwrence of angina 3 months 
after stentiw in a byeass exalt. Aneiomaohv revealed a 
severe narrowing within the stent that was treated by com- 
bined balloon andoolastv and atherectomv IFie. 8). The 
tissue specimen &&web by the athe&o&~de&e is 
shown in Figure 9. The microscopic evaluation shows abun- 
dant extracellular collagenous matrix and areas of marked 
cellulatity that stain positively for IWO smooth muscle cell 
cytoskeleton proteins, alpha actin and vimentin (Fig. IO). 
Although hyperplasia is a conseouence OF stent&. the 
functional significance of this arowth may be diminished. 
This is expl&ed by the in&sic dilating property OF the 
self-expanding stent, which initially improves ,uminal area 
5G% mare than angioplasty by itself and in many patients 
more than compensates For the late proliieration. Unfortu- 
nately. the ideal ratio of stent size to vessel size that will 
result in optimal dilation with minimal ~mpensatory hyper- 
plasia remains tmkown. The importance of this relation to 
the 6nal outcome was illustrated recently by a Mayo Clinic 
study (65) in which a model For restenosis was developed by 
implanting stainless steel and tantalum coils with markedly 
oversized angioplasty balloons inflated to high pressures up 
to 14 atm. 
Conforrnding Aspecrs of Stenting 
There are three additional aspects cf stenting that further 
confound our understanding of the processes occurring in 
the vessel wall after iqjury. 
1. Foreign h&y hteractim with the veal wall. In can- 
trast to brief, transient balloon-induced injury, nonbiode- 
gradable steots are pemtanent foreign bodies with poten- 
tially important interactions dar: to type of meta:, 
electrostatic charges, and possible physical irritariu;. frnm 
individual filaments. Whether the continued prwencc of a 
Figure 6. A. Transmission elcclron micrograph of saphenous vein 
bypass graft 6 months after stent implantation. Extracellular lipid 
deposits and cboleskrol clefts @wav) arc evident alongside the 
foam cells. B. Higher m.-gnikxian of another pan of the section in 
A. An abundant numbei of oam cells can k seen. The dixonal 
lines are artifacts produced by the ultramicmtome. PI =-void 
remesenline the she of s removed 70 urn diameter stem wire. 
Abbreviatkk as in Figure 5. 
Figure 7. Scanning electmn micrograph of the endotheliat lining 
shows an irregular. raised endotbelial surface. Two leukocykr are 
adherent to the endalhelium (bar = 5 pm). 
foreign body in the vascular wall will continue to stimulate 
fibrointimal byperplasia after the 6 months usually associ- 
ated with balloon injury is also unknown. Concern has also 
been expressed as lo whether the stent can trigger an allergic 
response. particularly in individuals who are hypersensitive 
to the individual metals that make ~‘9 the device. Although 
there have been reports of transient inflammatory mtiitrates 
in the adventitia alter stat implantation, it is reassuring that 
there have been no reports of foreign body cells in the 
immediate vicinity ofthe implanled device in the experimen- 
Figure 8. Coronary an&gram fmm a 61 year old patient who 
underwent stat implantation for a were narrowing in the shaft of 
a IO year old saphenous vein bypass grafl. Three months later he 
war treated with atherectomy for restenosis within the stem. 
Figure 9. Ligh, micrograph of byperplaslic 
tissue removed by athereclomy from rhe 
narrowed PM, in Fig. 8. The specimen ccm- 
tainsabundan, smwrb muscle cells and loose 
ex,race,,ulm matrix. IHematoxylin-eoain 
stain.) 
tal animal model (14.15). This has been conRrmed in limited 
experience in retrieved human s,en,ed coronary bypass 
grafls. In vitro attempts (Van der Giessen et al., unpublished 
observations) to identify endothelial membrane lipid perox- 
idation by free radicals folmed in the presence of metallic 
steot elements have been unsuccessful. although the theo- 
retic possibility exisrs. 
2. Lan+rm eUecl.s OF mntinu0us barotra~mn: mle of 
exerted radial orean. The chronic effects of continuous 
bamtrwma induced by the expanded steot may have impor- 
lam ramifications. Because the Wallstent’s properties are 
analogous to those of any spring. it oies to aswme its 
equilibrium confi$ura,ioo. defined ar Ihe unconstrained di- 
ameter where net radial force is zero. If it is srretcbed 
beyond or constricted below this equilibrium, it generater 
forces to return to this configuration. We have studied the in 
vitro force-length relationship of the Wallstent sten, (Fig. 
I I). These meawrementr have yielded calcolaiins of the 
radial pressures exerted by this stent. both globally and 
locally al the site of the individual filaments if the stat is 
RSure 10. Smooth muscle cells are id 
in ,he restenosis tissue obtained a, 
tomy by the dark brow -.-:-:-- ‘- --.: 
body specific for rmoalb 
has been coupled IO a ~~,vn,ua>~ I 
and is reswnsibk for the dark color. 
Figure II. Radial pressures ol the individual stem filament and the 
global pressure on the vessel wull of a self-expanding Walktent 
hmcanstraincd diameter 6.X mm) at varying degrees ofexpansion. 
maintained at a diameter less than that of the unconstrained 
diameter. Significant pressures are generated by the stent (as 
in any spring-loaded evice) to return it to its unconstrained 
size. For example, an unconstrained 6.25 mm diameter stent 
getterates a radial global pressure of 50 mm Hg and a radial 
local pressure of about 300 mm Hg at the steal filament if it 
is maintained at 5.5 mm. This increases to 90 mm globally 
and 500 mm locally at 4.5 mm diameter. These pressure 
calculations would be additive to the mean arterial pressure 
and could have an important impact in situations where 
oversized Wallstents are implanted. In fact, localized areas 
of necrosis adjacent to the stent wires have be n seen. which 
are probably the result of a pressure phenomenon. 
3. Splinting the artery externally (casting) versus internally 
(stcnting): effect cm wall stress. Parallels have been drawn 
between the etTects of splinting the artery externally (cast- 
ing) and internally (stenting). Thubikar et al. (64) showed 
that er~rnally casting segments of rabbit aortas limits pul- 
wile flow and atheroma development despite a high choles- 
terol diet. On the basis of this observation, others (321 have 
speculated that nonflexing internal stems may also reduce 
wall stress and consequently diminish hyperplasia fonua- 
[ion. However, this analogy is not impressive. Although 
some of the pulsatile stretch may be borne by the external 
cast or the internal stent, and thus favorably affect wall 
stress. this is achieved by separate means. In the casting 
model. there should be a reduction in intramural wall stress, 
since the vessel is casted at a radius smaller than the 
maximal systolic expansion. In contrast to casting. stenting 
results in dilation of tbe artery and an increase in wall stress. 
This imponant stimulus to intimal hyperplasia appears to 
overcome the inhibitory effects of reduction in phasic vessel 
wall expansion. Booth et al. (67) modified the external 
casting model with interesting results. By applying an exter- 
nal nonoccluding Silastic collar on a rabbit carotid attery 
that did nut affect end-systolic di.nensions, they demon- 
strated that focal hyperplastic lesions rapidly develop. This 
finding supports the concept that extemal casting must 
decrease the vessel radius in order to achieve inhibition of 
imimal hyperplasia. 
The State of Interventional Cardiology in 
1990: Debulking Versus Dilating 
Interventional cardiology has moved in two directions: 
devices that primarily dilate coronary narrowings (balloon 
angioplasty and stentingl and devices that physically debulk 
coronary tissue by extraction. liquefaction or vaporization 
(laser. directional and rotational atherectomy and spark 
eroriont. At present. it is difficult to make comparisons 
among the various devices. However. there are several 
fundamental differences that may be important and merit 
further discussion. 
Comparison of the various lechniques. The ideal coronary 
intervention should selectively reduce the e&cl of the 
atheromatous lesion with minimal alteration of the twmtal 
vessel wall components and architecture. None of the cur- 
rently available techniques completely satisfy these require- 
at&. Balloon ang&larty, aihereclomy (rotaliana~ and 
directionall and laser devices all cause extensive traumatic 
changes within the plaque and usually major alterations to 
the vessel wall architecture as well. Ballwn angioplasty, the 
earliest intervention. has been shown to create tears and 
dissections within and at the edges of atherosclerotic plaques 
and frequently disrupts the internal elastic membrane and 
medial layers (66-71). Theoretically. these disruptions may 
be advantageous ince the liberation of lipid and debris from 
the atheromatour lesions. a sort of debridement, may favor- 
ably affect the long-term biologic growth and behavior (if 
distal embalization of this material does not cause immediate 
clinical consequences) (72-74). 
However. atore important considerations may be the 
manner in which the healing process ensues in a damaged 
vessel with frayed, ragged membrane edges and separated 
muscular layers and the inherent problems of restoring the 
normal three-layered architecture of the arterial wall in an 
orderly fashion after such injury. Moreover, the extent of 
arterial disruption from angioplasty appears to be much less 
than in the actual removal of coronary tissue by debulking 
devices. Directional aiherectomy in particular has been 
shown to be extremely effective in removing the atheroma 
but specimens include adventitia in up to 30% of cases (75), 
although there is no evidence to date that the rate of 
restenosis is related tu the depth of the vessel wall extracted. 
Alternatively, stenting seems to be the least disruptive to the 
underlying architecture. although the underlying atheroma- 
tow lesion persists in the stewed vessel with unknown 
future consesuences. Stentina is able to “tack back” the 
cracks and tears induced by balloon angioplasty, which may 
Figure 12. The n plural progression of coronary arep/ disease as 
ruwsfed by Glagov e, “1. ,76, is illnsrrated 1” rhe ce”,e, r”w by the 
early compensatory enlargement and the late luminal narrowing of 
pmgressive atherorcleroria. The ditTere”,ial effecrs of slendng and 
atherectomy in restming the vessel diameter xe show”. Stentinp 
fbrhw) resm,~~ the early compensatory enlargeme”, in the ve9sel 
while it maimains the basic architecture of the vessel wall. By 
extracting vascular tissue. atherecmmy ~almve) disrupts the under- 
lyirgarchileclureoflhe wall. ModifiedfromGlagov Set al. 17h)wh 
permission. 
diminish the stimulus for fibrosis in much the fame way that 
a properly closed wound minimizes fibrotic scar in the 
healing phase. 
Glagm revbited. Glagov et al. (761 obrerved that the 
diseaxd coronary artery is able LO adapt to progressive 
plaque expan+n by enlarging the size of the vessel. This 
comwnwtory mechanism maintains the luminal area umil 
the plaque lesion occupies 407c of the arca inside the internal 
elastic lamina. beyond which progressive luminal narrowiag 
occur. In other words. significant atherosclerosis can CCXX- 
is, wth normal or eve” enlarged luminal area until the limits 
of this adaptation are exceeded. 
Striking cimilarilies exist between the chronic process of 
atherosclerosis and the situation i” the slated vessel wall. 
The stem is initially embedded in the inlima. which results 
immediately in enlargemtr of the lumen and later in local- 
ized mediai thinningVat the site of the s,em wires. a cam- 
manly observed path&& feature of atherosclerorir. Stem- 
ing may be regarded as rhe invasive cardmlogist‘s attempt to 
restore the aforementioned “Glaeovian” balance between 
plaque and luminal area. but in v&Is that contain plaques 
>40% of the internal elastic lamina IFie. I?). Stems eCc- 
tively alter the relation between plaque &e and lumen area. 
rewlting in a shill in the curve. Regressive vessel dilation 
by the stem co” maintain adequate luminal area unless 
excessive fihrointimal hyperplasia upsets the new balance. 
Expansion mlio. Expansion ratio is an importad concept 
thet relates the final &ect on the arterial diameter 10 the size 
of the catheter required to deliver this effect 02) (Table I). A 
favorable rue is best exemphfied by a small catheter 
delivery system that is able to pass severely narrowed 
segments and yet optimally dilalc the stenosis. The maximal 
effect of the device may be partially lost because of the 
elastic recoil of the vcsxl. The current interventional de- 
vices may have differential effects in these two areas: the 
immedrale reult when the device is mdrally used. and lhen 
the partial loss of the initial gain after the devics has been 
removed. An attempt has been made to separate these two 
effectc by wbdividrzg the expansion ratio into the theoretical 
expnsion ratio (a measure of the effect while the device is 
operationall and the functional expansion ratio (which takes 
into account the elastic recoil phenomenonl. For example. B 
4 mm diameter balloon angioplasty catheter should achieve a 
vessel drameter of 4 mm at the time of balloon inflation but 
this is reduced immediately after deflation. primarily be- 
cause of the elastic recoil of the vessel. Balloon angioplasty 
and stenting give extremely favorable theoretic and effective 
expansion ratios Gnce they may be delivered on low profile 
catheters. The wide range for the theoretic and effective 
expansion ratio5 seen with balloon angioplasty is explained 
by the variation in the size of the balloons (2.0 IO 3.5 mm) 
used in the study from which these data were obtained. The 
athercctomy d&ices arc more limited by the profile of the 
device that is introduced into the coronary artery. The 
dimensions of the rotational atbercctomy device and the 
excimer laser do not change while in operation and therefore 
both exhibit lower theoretic expansion ratios. However, by 
physically removing or vaporizing tissue, the potential elw 
tic recoil effect is diminished by atherectomy and excimer 
laser devices. 
Conclusion 
Once again the question is asked: Can the promises of the 
new technology, and in particular the coronary stent. ever be 
realized?. Stenting will only achieve clinical acceplance 
when the safety, efficacy and cost efficiency arc superior to 
those of halloon angioplasty alone. Safety remains the major 
limit&a of stenting. In the initial I05 patients with an 
im.oianted Wallstent. ;O% had documented occlusion within 
the 1st I4 days. usually resulting in myocardial infarction 
and in some cases necessitating emergrncy bypass surgery. 
With further experience this was reduced to 13% in the next 
lo0 patients. Scbatz et al. (15) recently reported a 3.6% 
subacute occlusion rate in contrast to a 16% rate in their 
early experience when warfarin treatment was omitted (78). 
However. the price of chronic anticoagulation therapy- 
bleeding complications. prolonged hospdalization to initiate 
therapy and effects on the qwlily of life-must also be 
considered. With the increasing importance of third party 
payment. the cost differential among competing therapies 
will also dictate medical policies. Finally, these devices musr 
show beneficial ell’cct on late rcstenosis in order to gain 
clinical acceptance. The late follow-uo results of ouantitative 
coronary angiography for two of the &nts will be published 
in the next several months and should provide more objec- 
tive evidence with which to evaluate the future role of the 
stent. 
The early experience of modern interventional cardiolow 
evoke5 lesson; contained within Pandora’s box. In this 
classic Greek myth, man. beguiled by the attraction of 
Pandora opened the box that exposed heretofore unknown 
perils and disease, while Hope (Elpis). the lone content of 
the box that could be controlled by man, remained hidden 
deer, within the box. The allure of the newer techniques and 
devices in interventional cardiology, like Pandora’bcrsclf, 
have brought us a new set of problems that we have been 
ineffectual in solving. However, Hope also exists within the 
modem Pandora’s box and our capacity to realize :rope will 
depend on a scientific approach to the problems of restenosis 
and neointirnal hyperplasia in a mutual effort (in concert with 
industry) of interventional cardiologists, pathologists, mo- 
tccular biologists. biochemists, pharmacologists and our 
patients. the general public. 
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